Reynoso Jamie L. 4

What Happened Jamie L. Reynoso, CEO (Medicare Advantage) of Clover Health (CLOV), reported the sale of 6,350 shares on 2026-06-15. The shares were disposed at a weighted average price of $4.61, for total proceeds of approximately $29,274. The filing indicates these sales were sell-to-cover transactions tied to tax withholding for vested restricted stock units (RSUs), not discretionary investment sales.

Key Details

• Transaction date: 2026-06-15; Form 4 filed: 2026-06-16 (appears timely; Form 4 is due within two business days).
• Shares sold: 6,350; weighted average price: $4.61; total proceeds: ~$29,274.
• Price range: $4.61 to $4.64 across multiple trades (report offers to provide per-price breakdown on request).
• Footnote: Sales were mandatory sell-to-cover to satisfy tax withholding on RSU vesting (not a voluntary sell).
• Shares owned after the transaction: not specified in the provided excerpt of the filing.

Context Sell-to-cover transactions are common when RSUs vest and are generally done to satisfy tax obligations; they do not necessarily reflect the insider’s view on the company’s prospects. Purchases are typically more informative about insider sentiment than routine tax-related sales.